Target intelligence / Profile preview

Dengue virus (serotype 1, 2, 3, or 4) (DENV-1, DENV-2, DENV-3, DENV-4)

Target
DENV-1, DENV-2, DENV-3, DENV-4
Molecular classification
Virus, Flaviviridae family, Flavivirus genus
01

Overview

The dengue viruses are single-stranded, positive-sense RNA viruses belonging to the genus Flavivirus, family Flaviviridae. There are four closely related but antigenically distinct serotypes, termed Dengue virus serotype 1 through 4 (DENV-1, DENV-2, DENV-3, DENV-4). Each serotype is capable of causing disease ranging from mild dengue fever to severe forms such as dengue hemorrhagic fever and dengue shock syndrome. The genome encodes three structural proteins (capsid, membrane, and envelope) and seven nonstructural proteins. Dengue viruses are primarily transmitted by Aedes mosquitoes, especially Aedes aegypti. Immunity to one serotype does not confer long-term protection against the others and, in fact, subsequent infection with a different serotype increases the risk of severe disease due to antibody-dependent enhancement[1][2][3][4][5][6]. Dengue remains a significant global public health concern, with vaccines under development and varying efficacy against the four serotypes.

Other names
Dengue virus 1Dengue virus 2Dengue virus 3Dengue virus 4DENV1DENV2DENV3DENV4Dengue virus serotype 1Dengue virus serotype 2Dengue virus serotype 3Dengue virus serotype 4
02

Mechanism of action

Vaccine-induced immune response (neutralizing antibodies against the envelope protein)

03

Biological functions

Viral infectionPathogen entryImmune evasionInduction of host immune response
04

Disease associations

InfectionDengue feverSevere dengue (Dengue hemorrhagic fever, Dengue shock syndrome)
05

Safety considerations

Antibody-dependent enhancement (ADE; increased risk of severe disease with secondary infection by a different serotype)Incomplete protection by some vaccines for all serotypes
06

Interacting drugs

Dengvaxia (vaccine)

2 more in the full profile.

07

Biomarkers

NS1 antigen (viral protein for early detection)Anti-DENV IgM/IgG (serology)Viral RNA (PCR detection)

Beyond the preview

Go deeper on Dengue virus (serotype 1, 2, 3, or 4) (DENV-1, DENV-2, DENV-3, DENV-4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dengue virus (serotype 1, 2, 3, or 4) (DENV-1, DENV-2, DENV-3, DENV-4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call